Brief: Propanc Biopharma Announces Strategic Financing Agreement Of Up To $100 Million With Hexstone Capital
15/10/2025 13:46
Oct 15 (Reuters) - Propanc Biopharma Inc PPCB.O: PROPANC BIOPHARMA ANNOUNCES STRATEGIC FINANCING AGREEMENT OF UP TO $100 MILLION WITH HEXSTONE CAPITAL PROPANC BIOPHARMA INC - PREFERRED STOCK CONVERTIBLE INTO COMMON STOCK AT $5.00 PER SHARE Source text: ID:nGNX2VnrdF Further company coverage: PPCB.O
Recent news on Propanc Biopharma
See all newsNASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition With Prp In Pancreatic Cancer Models, Contrasting Profile With Revolution Medicines’ Daraxonrasib
Brief: Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing
Brief: Propanc Biopharma To File Cta In Australia For Phase 1B Study In 30–40 Advanced Cancer Patients